BrightSpring Health Services, Inc. Welcomes Dr. Steve Miller to Board of Directors
BrightSpring Health Services (NASDAQ: BTSG) has appointed Dr. Steve Miller as a Class II member of its Board of Directors. Dr. Miller will serve on the Board's Audit Committee and chair the Quality & Compliance and Governance Committee. With decades of experience as a medical researcher, clinician, and administrator, Dr. Miller brings valuable expertise to BrightSpring.
Dr. Miller's notable career includes roles as Chief Clinical Officer at Cigna (2018-2022), Chief Medical Officer at Express Scripts (2005-2018), and Chief Medical Officer at Barnes-Jewish Hospital (1999-2005). He is currently the Chief Medical Officer at MediBeacon, a medical technology company.
BrightSpring's CEO, Jon Rousseau, expressed excitement about Dr. Miller joining the board, highlighting his unique insights into patient success. Dr. Miller stated his commitment to making a difference in healthcare and bringing his perspective to drive innovation at BrightSpring.
BrightSpring Health Services (NASDAQ: BTSG) ha nominato il Dr. Steve Miller come membro di Classe II del suo Consiglio di Amministrazione. Il Dr. Miller farà parte del Comitato di Revisione e presiederà il Comitato per la Qualità, la Conformità e la Governance. Con decenni di esperienza come ricercatore medico, clinico e amministratore, il Dr. Miller porta un valore aggiunto a BrightSpring.
La carriera notevole del Dr. Miller include ruoli come Chief Clinical Officer presso Cigna (2018-2022), Chief Medical Officer presso Express Scripts (2005-2018) e Chief Medical Officer presso il Barnes-Jewish Hospital (1999-2005). Attualmente è Chief Medical Officer presso MediBeacon, un'azienda di tecnologia medica.
Il CEO di BrightSpring, Jon Rousseau, ha espresso entusiasmo per l’ingresso del Dr. Miller nel consiglio, sottolineando le sue uniche intuizioni sul successo dei pazienti. Il Dr. Miller ha dichiarato il suo impegno a fare la differenza nella sanità e a portare la sua prospettiva per guidare l'innovazione in BrightSpring.
BrightSpring Health Services (NASDAQ: BTSG) ha nombrado al Dr. Steve Miller como miembro de Clase II de su Junta Directiva. El Dr. Miller formará parte del Comité de Auditoría y presidirá el Comité de Calidad, Cumplimiento y Gobernanza. Con décadas de experiencia como investigador médico, clínico y administrador, el Dr. Miller aporta una valiosa experiencia a BrightSpring.
La notable carrera del Dr. Miller incluye roles como Chief Clinical Officer en Cigna (2018-2022), Chief Medical Officer en Express Scripts (2005-2018) y Chief Medical Officer en el Barnes-Jewish Hospital (1999-2005). Actualmente es Chief Medical Officer en MediBeacon, una empresa de tecnología médica.
El CEO de BrightSpring, Jon Rousseau, expresó su entusiasmo por la incorporación del Dr. Miller a la junta, destacando sus perspectivas únicas sobre el éxito del paciente. El Dr. Miller afirmó su compromiso de hacer una diferencia en el cuidado de la salud y aportar su perspectiva para impulsar la innovación en BrightSpring.
BrightSpring Health Services (NASDAQ: BTSG)는 이사회의 2등급 이사로 Dr. Steve Miller를 임명했습니다. Dr. Miller는 감사위원회에서 활동하고 품질 및 준수, 거버넌스 위원회를 주관할 것입니다. 수십 년의 의료 연구자, 임상의, 관리자 경험을 가진 Dr. Miller는 BrightSpring에 귀중한 전문성을 제공합니다.
Dr. Miller의 주목할 만한 경력에는 Cigna의 최고 임상 책임자 (2018-2022), Express Scripts의 최고 의료 책임자 (2005-2018), Barnes-Jewish Hospital의 최고 의료 책임자 (1999-2005)와 같은 역할이 포함됩니다. 그는 현재 의료 기술 회사인 MediBeacon의 최고 의료 책임자로 재직 중입니다.
BrightSpring의 CEO인 Jon Rousseau는 Dr. Miller의 이사회 합류에 대해 기쁨을 표하며 그의 환자 성공에 대한 독특한 통찰력을 강조했습니다. Dr. Miller는 의료 분야에서 변화를 만드는 데 헌신하고 BrightSpring의 혁신을 이끌기 위한 자신의 관점을 제시하겠다고 밝혔습니다.
BrightSpring Health Services (NASDAQ: BTSG) a nommé le Dr Steve Miller en tant que membre de Classe II de son Conseil d'Administration. Le Dr Miller siégera au Comité d'audit et présidera le Comité Qualité, Conformité et Gouvernance. Fort de plusieurs décennies d'expérience en tant que chercheur médical, clinicien et administrateur, le Dr Miller apporte une expertise précieuse à BrightSpring.
La carrière remarquable du Dr Miller comprend des postes tels que Chief Clinical Officer chez Cigna (2018-2022), Chief Medical Officer chez Express Scripts (2005-2018) et Chief Medical Officer à l'hôpital Barnes-Jewish (1999-2005). Il est actuellement Chief Medical Officer chez MediBeacon, une entreprise de technologie médicale.
Le PDG de BrightSpring, Jon Rousseau, a exprimé son enthousiasme quant à l'arrivée du Dr Miller au conseil, soulignant ses perspectives uniques sur le succès des patients. Le Dr Miller a déclaré son engagement à faire la différence dans le secteur de la santé et à apporter sa vision pour stimuler l'innovation chez BrightSpring.
BrightSpring Health Services (NASDAQ: BTSG) hat Dr. Steve Miller als Mitglied der Klasse II in seinen Vorstand berufen. Dr. Miller wird Teil des Prüfungsausschusses sein und den Ausschuss für Qualität, Compliance und Governance leiten. Mit jahrzehntelanger Erfahrung als medizinischer Forscher, Kliniker und Administrator bringt Dr. Miller wertvolle Expertise zu BrightSpring.
Die bemerkenswerte Karriere von Dr. Miller umfasst Positionen als Chief Clinical Officer bei Cigna (2018-2022), Chief Medical Officer bei Express Scripts (2005-2018) und Chief Medical Officer des Barnes-Jewish Hospital (1999-2005). Derzeit ist er Chief Medical Officer bei MediBeacon, einem Unternehmen für Medizintechnologie.
Der CEO von BrightSpring, Jon Rousseau, äußerte sich begeistert über Dr. Millers Eintritt in den Vorstand und hob seine einzigartigen Einsichten in den Patientenerfolg hervor. Dr. Miller erklärte sein Engagement für eine Verbesserung im Gesundheitswesen und seine Perspektive zur Förderung von Innovationen bei BrightSpring.
- Appointment of Dr. Steve Miller, a nationally recognized healthcare advocate, to the Board of Directors
- Dr. Miller's extensive experience as a medical researcher, clinician, and administrator in various healthcare settings
- Dr. Miller's role in chairing the Quality & Compliance and Governance Committee, potentially enhancing BrightSpring's governance and quality standards
- None.
LOUISVILLE, Ky., Sept. 30, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “the Company”) (NASDAQ: BTSG), a leading provider of home- and community-based health services for complex populations, today announced that Dr. Steve Miller was appointed as a Class II member of the Board of Directors. Dr. Miller will also serve as a member of the Board’s Audit Committee and as the chair of the Board’s Quality & Compliance and Governance Committee.
As a nationally recognized advocate for greater access, affordability, and excellence in healthcare, Dr. Miller brings decades of experience to the Company as a medical researcher, clinician, and administrator across numerous healthcare settings and arenas.
Dr. Miller served as the Chief Clinical Officer for Cigna from 2018 to 2022, transitioning to an expert advisor role in 2022 for Cigna’s efforts across clinical policy, quality, and performance programs. Previously, Dr Miller was the Chief Medical Officer at Express Scripts from 2005 to 2018 and the Chief Medical Officer at Barnes-Jewish Hospital from 1999 to 2005. He is currently the Chief Medical Officer at MediBeacon, a medical technology company specializing in fluorescent tracer agents and transdermal measurement.
“We are excited to welcome Dr. Steve Miller, as a thought leader in healthcare, to our board,” said BrightSpring President and CEO Jon Rousseau. “Steve brings decades of experience as a clinical leader in the field, along with unique insights into drivers of patient success, from the lens of a clinician, medical administrator, and researcher. Dr. Miller will be a valued voice as we continue to work to create better solutions for patients and address challenging needs in healthcare.”
“I’m honored to join BrightSpring as a new Board member to help them succeed in their mission to better the lives of patients and communities,” said Dr. Steve Miller. “It has long been my focus to make a difference in healthcare. I believe my years of service as a clinician and researcher will bring a unique perspective to further drive innovation and success in the future, for BrightSpring, patients, and other key stakeholders in healthcare.”
Throughout his career, Dr. Miller has received countless awards and honors for his work, including the American Heart Association Scholar in Residence, the American Heart Association Clinician-Scientist Award, the Central Society for Clinical Research’s Young Investigator Award, Marquis Who’s Who in Medicine and Healthcare, the Olin School of Business Distinguished Alumni Award, and the Washington University Distinguished Alumni Award.
About BrightSpring Health Services
BrightSpring Health Services provides complementary and integrated home- and community-based pharmacy and health solutions for complex populations in need of specialized and/or chronic care. Through the Company’s service lines, including pharmacy, home health care and primary care, and rehabilitation and behavioral health, we provide comprehensive care and clinical solutions in all 50 states to over 400,000 customers, clients and patients daily.
Media Contact:
Leigh White
leigh.white@brightspringhealth.com
502.630.7412
FAQ
Who is Dr. Steve Miller and what position has he been appointed to at BrightSpring Health Services (BTSG)?
What is Dr. Steve Miller's background and experience in healthcare?
How does BrightSpring Health Services (BTSG) expect Dr. Steve Miller to contribute to the company?
What committees will Dr. Steve Miller be involved with on BrightSpring Health Services' (BTSG) Board of Directors?
